UNIV MISSOURI RESEARCH REACTOR CENTER
Overview
UNIV MISSOURI RESEARCH REACTOR CENTER is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering LUTETIUM (LU-177) CHLORIDE RADIOPHARMACEUTICAL PRECURSOR; NCA LUTETIUM LU-177 CHLORIDE SOLUTION; SODIUM IODIDE I-131 SOLUTION.
API / Drug Master Files
UNIV MISSOURI RESEARCH REACTOR CENTER holds 2 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- SODIUM IODIDE I-131 SOLUTIONActive2018-08-10
- LUTETIUM (LU-177) CHLORIDE RADIOPHARMACEUTICAL PRECURSORActive2016-01-08
- POTASSIUM MOLYBDATE (MO-99) FINAL INTERMEDIATE RADIOCHEMICALInactive2012-09-11
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to UNIV MISSOURI RESEARCH REACTOR CENTER in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this UNIV MISSOURI RESEARCH REACTOR CENTER? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.